Publications by authors named "David A Wolinsky"

Claim this Profile
D
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation.
Paul C Cremer, Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, Robier Aguillon Prada, David A Wolinsky

Eur Heart J Open· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.
Timothy M Bateman, Vasken Dilsizian, Rob S Beanlands, E Gordon DePuey, Gary V Heller, David A Wolinsky

J Nucl Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.
Timothy M Bateman, Vasken Dilsizian, Rob S Beanlands, E Gordon DePuey, Gary V Heller, David A Wolinsky

J Nucl Cardiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.
Timothy M Bateman, Vasken Dilsizian, Rob S Beanlands, E Gordon DePuey, Gary V Heller, David A Wolinsky

J Nucl Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis